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Chemicals combine with DNA, resulting in DNA damage, which could initiate carcinogenesis. To
study whether benzene or benzene metabolites bind to DNA, DNA adducts in various tissues and
their persistence in leukocytes were examined using the 32P-postlabeling assay. LACA mice were
dosed ip with benzene at 500 mg/kg bw twice daily for 5 days. Two additional spots of DNA
adducts are formed in bone marrow cells, liver cells, and peripheral blood compared with control
mice. The relative adduct labeling values are 10.39, 11.32, and 13.77 adducts x 108 nucleotides
in these tissues, respectively. DNA adducts in blood leukocytes were observed at 1, 4, 7, 14, and
21 days after exposure to benzene, but adduct levels decreased as a function of time. Relative
adduct labeling of "adduct B" declined linearly but mildly, while "adduct C" displayed a stepwise
decrease. The relative adduct labeling values of both these adducts at day 14 were 50% of those
at day 1 after the last treatment. Both adducts were still detectable at day 21 after benzene
exposure. These studies demonstrate that benzene could induce DNA adducts in bone marrow,
liver, and white blood cells of mice dosed with benzene and that measurement of adducts in
white blood cells may be useful as a biomarker to predict carcinogenic risk of benzene to workers
exposed to benzene. Environ Health Perspect 104(Suppl 6):1337-1338 (1996)
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Introduction
The relationship between benzene and
leukemia is well known. Benzene also
induces solid tumors in various tissues (1).
Benzene was listed as a human carcinogen
by the International Agency for Research on
Cancer (IARC) (2). There are a large num-
ber ofworkers exposed to benzene or ben-
zene-containing compounds (3). Although
the mechanism of benzene poisoning has
been studied for a long time, the mecha-
nism of carcinogenesis is uncertain. The
combination of chemical carcinogen and
DNA might initiate the process ofchemi-
cal carcinogenesis (e.g., the chemical may
undergo a reaction with DNA) (4). Over
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the past decade, the development oftech-
niques in molecular biology, particularly
the P1-enhanced 32P-postlabeling method
(5), has made it possible to detect DNA
adducts in a low molecular weight chemi-
cal carcinogen. Hence, it is now possible to
detect DNA adducts in vivo without
radioisotopic labeling of chemicals.
Whether benzene induces DNA adducts
and whether such adducts could be used as
biomarkers in human monitoring have
been ofgreat interest to many investigators.
Materials and Methods
Female LACA mice, 18-22 g, were divided
into five per group. In experiment 1, mice
were dosed ip with benzene at 500 mg/kg
bw twice daily for 5 days. Control mice
were treated with peanut oil. Blood, liver,
and bone marrow were collected at 24 hr
after the last benzene injection. Experiment
2 was the same as experiment 1 exccept
blood was collected at 1, 4, 7, 14, and 21
days after the last benzene injection.
Blood samples were collected from
postocular veins and pooled from five mice
of each group. Liver (0.2 g) and bone
marrow (single femur) were selected after
sampling blood. DNA was isolated by a
procedure involving solvent extraction and
enzymatic digestion ofprotein and RNA.
DNA adducts were analyzed by the
nuclease P1-enhanced version of32P-post
labeling assays. Briefly, 10 jig DNA was
digested with micrococcal nuclease and
spleen phosphodiesterase into 3'-mononu-
cleotides. The modified nucleotides were
first enriched by nuclease P1-catalyzed
dephosphorylation of normal nucleotides,
then labeled by (r-32P)ATP and T4-polynu-
cleotide kinase, and finallyseparated by mul-
tidimensional thin-layer chromatography.
Adducts were detected by autoradiography
and quantified byscintillation counting.
Results
Two DNA adducts are formed in all three
tissues (liver, bone marrow, and blood).
Spots B and C were identified as shown in
Figure 1. The number of DNA adducts
were counted as counts per minute using
scintillation counter by scraping the spots
in PEI-cellulose, comparing the corre-
sponding area in PEI-cellulose in the con-
trol group, and calculating the relative
adduct labeling (RAL) value. The results
are shown in Figure 2. The number of
DNA adducts in the tissues are 10.39,
11.32, and 13.77 x 10-8 in blood, liver
cells, and bone marrow cell, respectively.
RAL values in order were therefore bone
marrow>liver>blood.
As shown in Figure 1, two additional
spots (B,C) were noticed on the chro-
matograms of mice treated with benzene
compared with controls at 1, 4, 7, 14, and
21 days after the last exposure to benzene.
Figure 1. Autoradiograms of DNA adducts in white
blood cells of mice treated with benzene.
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Figure 2. Distribution of DNA adducts in various
tissues. WBC, white blood cells.
Levels ofthese two adducts decreased as a
function of time (Figure 3). Levels of
adduct B declined linearly but mildly while
adduct C displayed a stepwise decrease.
The RAL values ofboth adducts at 14 days
were 50% of those at 1 day after the last
exposure. Both adducts were still detectable
at 21 days after benzene exposure.
Discussion
Bone marrow is the target organ for ben-
zene and benzene is metabolized in liver
tissue. Peripheral blood is easy to sample
and can be available for human monitoring
compared with bone marrow and liver
cells. As shown in Figure 2, the level of
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Figure 3. Persistence of DNA adducts in mice treated
with benzene. 0, Adduct B; V, adduct C; *, sum of
both adducts.
DNA adducts are highest in bone marrow,
lowest in peripheral blood, and medium in
liver tissue. This reveals the different func-
tion ofvarious tissue in regard to benzene
metabolism. Bone marrow could accumu-
late benzene and its metabolites. For this
reason, there is more opportunity for ben-
zene metabolites to react with DNA in
bone marrow cells and to form DNA
adduct in this tissue. Crewet et al. (6)
detected radioactivity in various tissues and
reported similar results for DNA adduct
levels: bone marrow> liver > peripheral
blood. Bodell et al. (7) found three DNA
adducts in human bone marrow cells
cultured with benzoquinone using the
32P-postlabeling assay. Snyder et al. (8)
detected DNA adduct peaks in rats treated
with benzene, and DNA adducts were mea-
sured in 500- to 9000-g samples of liver
cells in rabbits dosed with benzene (9).
DNA adducts present in peripheral blood
could come from DNA adducts formed in
bone marrow or formed during the period
oftransport ofbenzene metabolites, which
could react with DNA ofwhite blood cells
from liver to bone marrow. Although levels
ofadduct in blood are lower, blood is easy
to sample. Blood sampling is of signifi-
cance in predicting the risk from benzene
carcinogenesis to human.
DNA adducts rose the first day after
exposure ended and stayed at this level
about 4 days. Benzene is absorbed and
metabolized quickly after ip injection.
Therefore, benzene metabolites react spon-
taneously with DNA. The level of DNA
adducts reflect a dynamic equilibrium in
the body between formation of DNA
adducts and the repair function ofDNA. A
trend ofdeclining RAL is shown after the
first 4 days. This may relate to repair func-
tion of DNA. The persistence of DNA
adducts illustrates not only the carcinogen-
esis of benzene and its metabolites but it
also provides a scientific basis for sampling
time ofbiomonitoring to humans.
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